{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T07:11:27Z","timestamp":1789456287925,"version":"build-2803163510"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Immunol"],"published-print":{"date-parts":[[2005,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Eradication of the smallpox virus through extensive global vaccination efforts has resulted in one of the most important breakthroughs in medical history, saving countless lives from the severe morbidity and mortality that is associated with this disease. Although smallpox is now extinct in nature, laboratory stocks of this virus still remain and the subject of smallpox vaccination has gained renewed attention due to the potential risk that smallpox may be used as a biological weapon by terrorists or rogue states. Despite having the longest history of any modern vaccine, there is still much to be learned about smallpox vaccination and the correlates of protection remain to be formally defined. This Commentary will discuss the strengths and weaknesses of traditional smallpox vaccination in comparison with immunization using modified vaccinia virus Ankura (MVA), a non-replicating virus with a strong safety record but weakened immunogenicity.<\/jats:p>","DOI":"10.1186\/1476-9433-4-2","type":"journal-article","created":{"date-parts":[[2005,3,2]],"date-time":"2005-03-02T07:25:35Z","timestamp":1109748335000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["The Future of Smallpox Vaccination: is MVA the key?"],"prefix":"10.1186","volume":"4","author":[{"given":"Mark K","family":"Slifka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,3,1]]},"reference":[{"key":"11_CR1","volume-title":"The pathogenesis, immunology, and pathology of smallpox and vaccinia","author":"F Fenner","year":"1988","unstructured":"Fenner F, Henderson DA, Arita I, Jezek Z, Ladnyi ID: Smallpox and its eradication. The pathogenesis, immunology, and pathology of smallpox and vaccinia. 1988, Geneva, World Health Organization"},{"key":"11_CR2","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/nri845","volume":"2","author":"GL Smith","year":"2002","unstructured":"Smith GL, McFadden G: Smallpox: anything to declare?. Nat Rev Immunol. 2002, 2: 521-527. 10.1038\/nri845.","journal-title":"Nat Rev Immunol"},{"key":"11_CR3","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1128\/JVI.75.3.1205-1210.2001","volume":"75","author":"RJ Jackson","year":"2001","unstructured":"Jackson RJ, Ramsay AJ, Christensen CD, Beaton S, Hall DF, Ramshaw IA: Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox. J Virol. 2001, 75: 1205-1210. 10.1128\/JVI.75.3.1205-1210.2001.","journal-title":"J Virol"},{"key":"11_CR4","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1056\/NEJMsb022994","volume":"348","author":"T Mack","year":"2003","unstructured":"Mack T: A Different View of Smallpox and Vaccination. N Engl J Med. 2003, 348: 460-463. 10.1056\/NEJMsb022994.","journal-title":"N Engl J Med"},{"key":"11_CR5","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.det.2004.03.002","volume":"22","author":"MK Slifka","year":"2004","unstructured":"Slifka MK, Hanifin JM: Smallpox: The Basics. Dermatol Clin. 2004, 22: 263-74, vi.","journal-title":"Dermatol Clin"},{"key":"11_CR6","volume-title":"An inquiry into the causes and effects of the variole vaccine, or cow-pox","author":"E Jenner","year":"1798","unstructured":"Jenner E: An inquiry into the causes and effects of the variole vaccine, or cow-pox. 1798, London"},{"key":"11_CR7","volume-title":"A continuation of facts and observations relative to the variole vaccine, or cow-pox","author":"E Jenner","year":"1800","unstructured":"Jenner E: A continuation of facts and observations relative to the variole vaccine, or cow-pox. 1800, London"},{"key":"11_CR8","first-page":"1149","volume":"113","author":"H Stickl","year":"1971","unstructured":"Stickl H, Hochstein-Mintzel V: [Intracutaneous smallpox vaccination with a weak pathogenic vaccinia virus (\"MVA virus\")]. Munch Med Wochenschr. 1971, 113: 1149-1153.","journal-title":"Munch Med Wochenschr"},{"key":"11_CR9","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1055\/s-0028-1108143","volume":"99","author":"H Stickl","year":"1974","unstructured":"Stickl H, Hochstein-Mintzel V, Mayr A, Huber HC, Schafer H, Holzner A: [MVA vaccination against smallpox: clinical tests with an attenuated live vaccinia virus strain (MVA) (author's transl)]. Dtsch Med Wochenschr. 1974, 99: 2386-2392.","journal-title":"Dtsch Med Wochenschr"},{"key":"11_CR10","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1086\/513968","volume":"175","author":"DJ McClain","year":"1997","unstructured":"McClain DJ, Harrison S, Yeager CL, Cruz J, Ennis FA, Gibbs P, Wright MS, Summers PL, Arthur JD, Graham JA: Immunologic responses to vaccinia vaccines administered by different parenteral routes. J Infect Dis. 1997, 175: 756-763.","journal-title":"J Infect Dis"},{"key":"11_CR11","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1001\/jama.1970.03170160031005","volume":"212","author":"JM Lane","year":"1970","unstructured":"Lane JM, Ruben FL, Abrutyn E, Millar JD: Deaths attributable to smallpox vaccination, 1959 to 1966, and 1968. Jama. 1970, 212: 441-444. 10.1001\/jama.212.3.441.","journal-title":"Jama"},{"key":"11_CR12","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1056\/NEJM196911272812201","volume":"281","author":"JM Lane","year":"1969","unstructured":"Lane JM, Ruben FL, Neff JM, Millar JD: Complications of smallpox vaccination, 1968. N Engl J Med. 1969, 281: 1201-1208.","journal-title":"N Engl J Med"},{"key":"11_CR13","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1056\/NEJM196701192760301","volume":"276","author":"JM Neff","year":"1967","unstructured":"Neff JM, Lane JM, Pert JH, Moore R, Millar JD, Henderson DA: Complications of smallpox vaccination. I. National survey in the United States, 1963. N Engl J Med. 1967, 276: 125-132.","journal-title":"N Engl J Med"},{"key":"11_CR14","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1093\/aje\/kwh269","volume":"160","author":"MK Arness","year":"2004","unstructured":"Arness MK, Eckart RE, Love SS, Atwood JE, Wells TS, Engler RJ, Collins LC, Ludwig SL, Riddle JR, Grabenstein JD, Tornberg DN: Myopericarditis following smallpox vaccination. Am J Epidemiol. 2004, 160: 642-651. 10.1093\/aje\/kwh269.","journal-title":"Am J Epidemiol"},{"key":"11_CR15","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jacc.2004.05.004","volume":"44","author":"RE Eckart","year":"2004","unstructured":"Eckart RE, Love SS, Atwood JE, Arness MK, Cassimatis DC, Campbell CL, Boyd SY, Murphy JG, Swerdlow DL, Collins LC, Riddle JR, Tornberg DN, Grabenstein JD, Engler RJ: Incidence and follow-up of inflammatory cardiac complications after smallpox vaccination. J Am Coll Cardiol. 2004, 44: 201-205. 10.1016\/j.jacc.2004.05.004.","journal-title":"J Am Coll Cardiol"},{"key":"11_CR16","first-page":"933","volume":"52","author":"CDC","year":"2003","unstructured":"CDC: Cardiac deaths after a mass smallpox vaccination campaign--New York City, 1947. MMWR Morb Mortal Wkly Rep. 2003, 52: 933-936.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"11_CR17","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1038\/nm916","volume":"9","author":"R Weltzin","year":"2003","unstructured":"Weltzin R, Liu J, Pugachev KV, Myers GA, Coughlin B, Blum PS, Nichols R, Johnson C, Cruz J, Kennedy JS, Ennis FA, Monath TP: Clonal vaccinia virus grown in cell culture as a new smallpox vaccine. Nat Med. 2003, 9: 1125-1130. 10.1038\/nm916.","journal-title":"Nat Med"},{"key":"11_CR18","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/0264-410X(94)00019-J","volume":"13","author":"L Kutinova","year":"1995","unstructured":"Kutinova L, Ludvikova V, Simonova V, Otavova M, Krystofova J, Hainz P, Press M, Kunke D, Vonka V: Search for optimal parent for recombinant vaccinia virus vaccines. Study of three vaccinia virus vaccinal strains and several virus lines derived from them. Vaccine. 1995, 13: 487-493. 10.1016\/0264-410X(94)00019-J.","journal-title":"Vaccine"},{"key":"11_CR19","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1099\/0022-1317-79-2-347","volume":"79 ( Pt 2)","author":"I Drexler","year":"1998","unstructured":"Drexler I, Heller K, Wahren B, Erfle V, Sutter G: Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells. J Gen Virol. 1998, 79 ( Pt 2): 347-352.","journal-title":"J Gen Virol"},{"key":"11_CR20","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/S0264-410X(00)00191-2","volume":"19","author":"N Kanesa-thasan","year":"2000","unstructured":"Kanesa-thasan N, Smucny JJ, Hoke CH, Marks DH, Konishi E, Kurane I, Tang DB, Vaughn DW, Mason PW, Shope RE: Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus--poxvirus vaccines in vaccinia- nonimmune and vaccinia-immune humans. Vaccine. 2000, 19: 483-491. 10.1016\/S0264-410X(00)00191-2.","journal-title":"Vaccine"},{"key":"11_CR21","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2174\/1568005033481123","volume":"3","author":"G Sutter","year":"2003","unstructured":"Sutter G, Staib C: Vaccinia vectors as candidate vaccines: the development of modified vaccinia virus Ankara for antigen delivery. Curr Drug Targets Infect Disord. 2003, 3: 263-271.","journal-title":"Curr Drug Targets Infect Disord"},{"key":"11_CR22","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.copbio.2004.09.001","volume":"15","author":"I Drexler","year":"2004","unstructured":"Drexler I, Staib C, Sutter G: Modified vaccinia virus Ankara as antigen delivery system: how can we best use its potential?. Curr Opin Biotechnol. 2004, 15: 506-512. 10.1016\/j.copbio.2004.09.001.","journal-title":"Curr Opin Biotechnol"},{"key":"11_CR23","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1056\/NEJMoa013431","volume":"346","author":"SE Frey","year":"2002","unstructured":"Frey SE, Newman FK, Cruz J, Shelton WB, Tennant JM, Polach T, Rothman AL, Kennedy JS, Wolff M, Belshe RB, Ennis FA: Dose-related effects of smallpox vaccine. N Engl J Med. 2002, 346: 1275-1280. 10.1056\/NEJMoa013431.","journal-title":"N Engl J Med"},{"key":"11_CR24","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1001\/jama.289.24.3295","volume":"289","author":"SE Frey","year":"2003","unstructured":"Frey SE, Newman FK, Yan L, Belshe RB: Response to smallpox vaccine in persons immunized in the distant past. Jama. 2003, 289: 3295-3299. 10.1001\/jama.289.24.3295.","journal-title":"Jama"},{"key":"11_CR25","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/S0140-6736(05)70234-8","volume":"365","author":"RN Greenberg","year":"2005","unstructured":"Greenberg RN, Kennedy JS, Clanton DJ, Plummer EA, Hague L, Cruz J, Ennis FA, Blackwelder WC, Hopkins RJ: Safety and immunogenicity of new cell-cultured smallpox vaccine compared with calf-lymph derived vaccine: a blind, single-centre, randomised controlled trial. Lancet. 2005, 365: 398-409. 10.1016\/S0140-6736(05)17827-1.","journal-title":"Lancet"},{"key":"11_CR26","doi-asserted-by":"publisher","first-page":"4969","DOI":"10.4049\/jimmunol.171.10.4969","volume":"171","author":"S Crotty","year":"2003","unstructured":"Crotty S, Felgner P, Davies H, Glidewell J, Villarreal L, Ahmed R: Cutting Edge: Long-Term B Cell Memory in Humans after Smallpox Vaccination. J Immunol. 2003, 171: 4969-4973.","journal-title":"J Immunol"},{"key":"11_CR27","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1086\/340517","volume":"185","author":"FA Ennis","year":"2002","unstructured":"Ennis FA, Cruz J, Demkowicz Jr WE, Rothman AL, McClain DJ: Primary Induction of Human CD8+ Cytotoxic T Lymphocytes and Interferon- gamma-Producing T Cells after Smallpox Vaccination. J Infect Dis. 2002, 185: 1657-1659. 10.1086\/340517.","journal-title":"J Infect Dis"},{"key":"11_CR28","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1084\/jem.20022222","volume":"197","author":"M Terajima","year":"2003","unstructured":"Terajima M, Cruz J, Raines G, Kilpatrick ED, Kennedy JS, Rothman AL, Ennis FA: Quantitation of CD8+ T Cell Responses to Newly Identified HLA-A*0201-restricted T Cell Epitopes Conserved Among Vaccinia and Variola (Smallpox) Viruses. J Exp Med. 2003, 197: 927-932. 10.1084\/jem.20022222.","journal-title":"J Exp Med"},{"key":"11_CR29","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1128\/JVI.76.7.3329-3337.2002","volume":"76","author":"LE Harrington","year":"2002","unstructured":"Harrington LE, Most Rv R, Whitton JL, Ahmed R: Recombinant vaccinia virus-induced T-cell immunity: quantitation of the response to the virus vector and the foreign epitope. J Virol. 2002, 76: 3329-3337. 10.1128\/JVI.76.7.3329-3337.2002.","journal-title":"J Virol"},{"key":"11_CR30","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1073\/pnas.262668999","volume":"100","author":"I Drexler","year":"2003","unstructured":"Drexler I, Staib C, Kastenmuller W, Stevanovic S, Schmidt B, Lemonnier FA, Rammensee HG, Busch DH, Bernhard H, Erfle V, Sutter G: Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines. Proc Natl Acad Sci U S A. 2003, 100: 217-222. 10.1073\/pnas.262668999.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11_CR31","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.3201\/eid0911.030349","volume":"9","author":"F Poccia","year":"2003","unstructured":"Poccia F, Gioia C, Montesano C, Martini F, Horejsh D, Castilletti C, Pucillo L, Capobianchi MR, Ippolito G: Flow cytometry and T-cell response monitoring after smallpox vaccination. Emerg Infect Dis. 2003, 9: 1468-1470.","journal-title":"Emerg Infect Dis"},{"key":"11_CR32","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/nm917","volume":"9","author":"E Hammarlund","year":"2003","unstructured":"Hammarlund E, Lewis MW, Hansen SG, Strelow LI, Nelson JA, Sexton GJ, Hanifin JM, Slifka MK: Duration of antiviral immunity after smallpox vaccination. Nature Medicine. 2003, 9: 1131-1137. 10.1038\/nm917.","journal-title":"Nature Medicine"},{"key":"11_CR33","doi-asserted-by":"publisher","first-page":"3811","DOI":"10.1128\/JVI.78.8.3811-3816.2004","volume":"78","author":"RR Amara","year":"2004","unstructured":"Amara RR, Nigam P, Sharma S, Liu J, Bostik V: Long-lived poxvirus immunity, robust CD4 help, and better persistence of CD4 than CD8 T cells. J Virol. 2004, 78: 3811-3816. 10.1128\/JVI.78.8.3811-3816.2004.","journal-title":"J Virol"},{"key":"11_CR34","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1111\/j.1365-2133.1994.tb04969.x","volume":"131","author":"D Baxby","year":"1994","unstructured":"Baxby D, Bennett M, Getty B: Human cowpox 1969-93: a review based on 54 cases. Br J Dermatol. 1994, 131: 598-607.","journal-title":"Br J Dermatol"},{"key":"11_CR35","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.3201\/eid0911.020814","volume":"9","author":"PM Pelkonen","year":"2003","unstructured":"Pelkonen PM, Tarvainen K, Hynninen A, Kallio ER, Henttonen K, Palva A, Vaheri A, Vapalahti O: Cowpox with severe generalized eruption, Finland. Emerg Infect Dis. 2003, 9: 1458-1461.","journal-title":"Emerg Infect Dis"},{"key":"11_CR36","doi-asserted-by":"publisher","first-page":"434","DOI":"10.3201\/eid0703.017311","volume":"7","author":"YJ Hutin","year":"2001","unstructured":"Hutin YJ, Williams RJ, Malfait P, Pebody R, Loparev VN, Ropp SL, Rodriguez M, Knight JC, Tshioko FK, Khan AS, Szczeniowski MV, Esposito JJ: Outbreak of human monkeypox, Democratic Republic of Congo, 1996 to 1997. Emerg Infect Dis. 2001, 7: 434-438.","journal-title":"Emerg Infect Dis"},{"key":"11_CR37","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1056\/NEJMoa032299","volume":"350","author":"KD Reed","year":"2004","unstructured":"Reed KD, Melski JW, Graham MB, Regnery RL, Sotir MJ, Wegner MV, Kazmierczak JJ, Stratman EJ, Li Y, Fairley JA, Swain GR, Olson VA, Sargent EK, Kehl SC, Frace MA, Kline R, Foldy SL, Davis JP, Damon IK: The detection of monkeypox in humans in the Western Hemisphere. N Engl J Med. 2004, 350: 342-350. 10.1056\/NEJMoa032299.","journal-title":"N Engl J Med"},{"key":"11_CR38","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nature02331","volume":"428","author":"PL Earl","year":"2004","unstructured":"Earl PL, Americo JL, Wyatt LS, Eller LA, Whitbeck JC, Cohen GH, Eisenberg RJ, Hartmann CJ, Jackson DL, Kulesh DA, Martinez MJ, Miller DM, Mucker EM, Shamblin JD, Zwiers SH, Huggins JW, Jahrling PB, Moss B: Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox. Nature. 2004, 428: 182-185. 10.1038\/nature02331.","journal-title":"Nature"},{"key":"11_CR39","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/0966-842X(96)10059-7","volume":"4","author":"MK Slifka","year":"1996","unstructured":"Slifka MK, Ahmed R: Long-term humoral immunity against viruses: revisiting the issue of plasma cell longevity. Trends Microbiol. 1996, 4: 394-400. 10.1016\/0966-842X(96)10059-7.","journal-title":"Trends Microbiol"},{"key":"11_CR40","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.coi.2004.05.013","volume":"16","author":"MK Slifka","year":"2004","unstructured":"Slifka MK: Immunological memory to viral infection. Curr Opin Immunol. 2004, 16: 443-450. 10.1016\/j.coi.2004.05.013.","journal-title":"Curr Opin Immunol"},{"key":"11_CR41","first-page":"523","volume":"48","author":"JK Sarkar","year":"1973","unstructured":"Sarkar JK, Mitra AC, Mukherjee MK, De SK: Virus excretion in smallpox. 2. Excretion in the throats of household contacts. Bull World Health Organ. 1973, 48: 523-527.","journal-title":"Bull World Health Organ"},{"key":"11_CR42","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/oxfordjournals.aje.a121319","volume":"94","author":"GG Heiner","year":"1971","unstructured":"Heiner GG, Fatima N, Daniel RW, Cole JL, Anthony RL, McCrumb FRJ: A study of inapparent infection in smallpox. Am J Epidemiol. 1971, 94: 252-268.","journal-title":"Am J Epidemiol"},{"key":"11_CR43","volume-title":"Studies in smallpox and vaccination","author":"W Hanna","year":"1913","unstructured":"Hanna W: Studies in smallpox and vaccination. 1913, New York, William Wood and Company"},{"key":"11_CR44","doi-asserted-by":"publisher","first-page":"9458","DOI":"10.1073\/pnas.1233578100","volume":"100","author":"IM Belyakov","year":"2003","unstructured":"Belyakov IM, Earl P, Dzutsev A, Kuznetsov VA, Lemon M, Wyatt LS, Snyder JT, Ahlers JD, Franchini G, Moss B, Berzofsky JA: Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses. Proc Natl Acad Sci U S A. 2003, 100: 9458-9463. 10.1073\/pnas.1233578100.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11_CR45","doi-asserted-by":"publisher","first-page":"6265","DOI":"10.4049\/jimmunol.172.10.6265","volume":"172","author":"R Xu","year":"2004","unstructured":"Xu R, Johnson AJ, Liggitt D, Bevan MJ: Cellular and humoral immunity against vaccinia virus infection of mice. J Immunol. 2004, 172: 6265-6271.","journal-title":"J Immunol"},{"key":"11_CR46","doi-asserted-by":"publisher","first-page":"4590","DOI":"10.1073\/pnas.0401165101","volume":"101","author":"LS Wyatt","year":"2004","unstructured":"Wyatt LS, Earl PL, Eller LA, Moss B: Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge. Proc Natl Acad Sci U S A. 2004, 101: 4590-4595. 10.1073\/pnas.0401165101.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11_CR47","first-page":"307","volume":"52","author":"JK Sarkar","year":"1975","unstructured":"Sarkar JK, Mitra AC, Mukherjee MK: The minimum protective level of antibodies in smallpox. Bull World Health Organ. 1975, 52: 307-311.","journal-title":"Bull World Health Organ"},{"key":"11_CR48","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4269\/ajtmh.1972.21.214","volume":"21","author":"TM Mack","year":"1972","unstructured":"Mack TM, Noble JJ, Thomas DB: A prospective study of serum antibody and protection against smallpox. Am J Trop Med Hyg. 1972, 21: 214-218.","journal-title":"Am J Trop Med Hyg"},{"key":"11_CR49","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1128\/am.25.4.539-544.1973","volume":"25","author":"RA Mason","year":"1973","unstructured":"Mason RA, Tauraso NM, Spertzel RO, Ginn RK: Yellow fever vaccine: direct challenge of monkeys given graded doses of 17D vaccine. Appl Microbiol. 1973, 25: 539-544.","journal-title":"Appl Microbiol"}],"container-title":["Medical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1476-9433-4-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T19:53:25Z","timestamp":1630612405000},"score":1,"resource":{"primary":{"URL":"https:\/\/medimmunol.biomedcentral.com\/articles\/10.1186\/1476-9433-4-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["11"],"URL":"https:\/\/doi.org\/10.1186\/1476-9433-4-2","relation":{},"ISSN":["1476-9433"],"issn-type":[{"value":"1476-9433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3,1]]},"assertion":[{"value":"27 February 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"2"}}